Xinpeng Zhou

Xinpeng Zhou


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in Medicine
Verified
Journal Article
Open access
XLXueping Lun
Xueping Lun
JYJianguo Yang
Jianguo Yang
YLYing Liu
Ying Liu
FZFuyu Zhao
Fuyu Zhao
ZWZhiliang Bm Wei
Zhiliang Bm Wei
XZXinpeng Zhou
Xinpeng Zhou
Background: To investigate the risk factors for the development of pulmonary arterial hypertension (PAH) in patients with systemic lupus erythematosus (SLE). Methods: The literature related to risk factors for the development of PAH in SLE patients was searched by the computer on China national knowledge infrastructure (CNKI), PubMed, and Embase, and the literature search was limited to the period of library construction to October 2022. Two researchers independently performed literature screening and literature information extracting, including first author, publication time, case collection time, sample size, and study factors, and used the Newcastle-Ottawa Scale (NOS) to evaluate the quality of the literature. The relationship between each clinical manifestation and laboratory index and the occurrence of PAH in SLE patients was evaluated based on the ratio (OR value) and its 95% CI. Results: A total of 24 publications were included, including 23 case-control studies and 1 cohort study with NOS ≥ 6, and the overall quality of the literature was high. The risk of PAH was higher in SLE patients who developed Raynaud phenomenon than in those who did not [OR = 2.39, 95% CI (1.91, 2.99), P < .05]; the risk of PAH was higher in SLE patients who were positive for anti-RNP antibodies than in those who were negative for anti-RNP antibodies [OR = 1.77, 95% CI (1.17, 3.2.65), P < .05]; the risk of PAH was higher in SLE patients with interstitial lung lesions than in those without combined interstitial lung lesions [OR = 3.28, 95% CI (2.37, 4.53), P < .05]; the risk of PAH was higher in SLE patients with combined serositis than in those without serositis [OR = 2.28, 95% CI (1.83, 2.84), P < .05]. The risk of PAH was higher in SLE patients with combined pericardial effusion than in those without pericardial effusion [OR = 2.97, 95% CI (2.37, 3.72), P < .05]; the risk of PAH was higher in SLE patients with combined vasculitis than in those without vasculitis [OR = 1.50, 95% CI (1.08, 2.07), P < .05]; rheumatoid factor-positive SLE patients had a higher risk of PAH than those with rheumatoid factor-negative [OR = 1.66, 95% CI (1.24, 2.24), P < .05]. Conclusion: Raynaud phenomenon, vasculitis, anti-RNP antibodies, serositis, interstitial lung lesions, rheumatoid factor, and pericardial effusion are risk factors for the development of PAH in patients with SLE.

8 September 2023 in Medicine
Verified
Journal Article
Open access
JYJianguo Mm Yang
Jianguo Mm Yang
FZFuyu Mm Zhou
Fuyu Mm Zhou
XZXinpeng Zhou
Xinpeng Zhou
YSYuying Sun
Yuying Sun
XLXueping Lun
Xueping Lun
BFBing Fan
Bing Fan
Background: The study aimed to evaluate survival rates and prognosis in systemic lupus erythematosus (SLE) patients with pulmonary hypertension (PH) using meta-analysis. Methods: PubMed, EMBASE, Cochrane central register of controlled trials, China National Knowledge Infrastructure, China Science and Technology Journal Database, Wan-Fang Database, and Chinese biomedical database were searched. Information and data were screened and extracted by 2 researchers. The obtained data were analyzed using the R software meta package. Quality assessment was conducted using Newcastle-Ottawa Scale. The causes of heterogeneity were analyzed using subgroup analysis and sensitivity analysis. Publication bias was evaluated using Begger funnel plots and Egger test. Results: The search strategy yielded a total of 21 studies involving 875 patients included in the final analysis. The pooled 1-, 3- and 5-year survival rates of patients with SLE-PH were 0.9020 (95%CI: 0.8576; 0.9397), 0.8363 (96%CI: 0.7813; 0.8852), 0.7301 (95%CI: 0.6327; 0.8181). The 1-, 3- and 5-year survival rates of echocardiography subgroup were 0.9000 (95%CI: 0.8480; 0.9551), 0.8435 (95%CI: 0.7744; 0.9187), 0.6795 (95%CI: 0.5746; 0.8035), respectively; and there were 0.9174 (95%CI: 0.8951; 0.9402), 0.8529 (95%CI: 0.8255; 0.8812), 0.7757 (95%CI: 0.7409; 0.8121) at right heart catheterization subgroup in the meantime. Multivariate analysis for predicting mortality in SLE-PH patients revealed that diminishing left ventricular ejection fraction, New York Heart Association classification, lupus nephritis, lower cardiac index, and higher red blood cell distribution width level were significantly associated with a higher mortality rate. Treatment with huge doses of cyclophosphamide, tricuspid annular plane systolic excursion/pulmonary artery systolic pressure, and Raynaud phenomenon signaled favorable outcomes. Conclusion: The 1-, 3-, and 5-year survival rates of SLE-PH patients in recent years (0.9020, 0.8363, 0.7301) were estimated in this study. SLE-PH patients diagnosed by echocardiography have a worse long-term prognosis than those diagnosed by right heart catheterization. Studies after 2015 have shown significantly better survival than earlier studies.

13 May 2021 in Research Square
Verified
Preprint
Open access
PDF file
RZRunrun Zhang
Runrun Zhang
YJYehua Jin
Yehua Jin
CCcen chang
cen chang
XZXinpeng Zhou
Xinpeng Zhou
YBYanqin Bian
Yanqin Bian
DHDongyi He
Dongyi He
Objective: This study identified to provide a comprehensive understanding of genome-wide expression patterns of synovial tissue from rheumatoid arthritis (RA) patients to investigate the potential mechanism RA occurrence and development. Methods: The transcription profiles of 9 RA and 15 control (osteoarthritis OA) synovial tissue were generated by RNA-Seq. Gene set enrichment analysis (GSEA) was used to analyze all detected genes and differentially expressed genes (DEGs) were identified by DESeq. To further analyze the DEGs, Gene ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed. The protein-protein interaction (PPI) network of DEGs were constructed by STRING and the hub genes were identified by topology clustering with MCODE-Cytoscape. The most important hub genes were validated by quantitative real time polymerase chain reaction (qRT-PCR). Results: A total of 17736 genes were detected and 651 DEGs were identified. For the GSEA, significantly enriched gene sets positively correlated with the RA group were CD40 signaling over-activation, Th1 cytotoxic module in C2, over-activation of immune response, adaptive immune response in C5, In C7, the up-regulation of the gene set of effective versus memory CD8 T cell is related to RA group. The down-regulation of gene set of naïve versus effective CD8 T cell is related to RA group.in C7. Biology process enrichment analysis showed that the DEGs were significantly enriched for signal transduction (P=1.52×10-08), immune response (P=1.94×10-22) and inflammatory response (P=1.11×10-11). Molecule function enrichment analysis revealed over-represented calcium ion binding (P=8.61×10-03), receptor binding (P=7.03×10-05) and chemokine activity (P=4.15×10-15). The DEGs were significantly enriched for plasma membrane (P=2.26×10-20), integral component of membrane (P=7.79×10-07), extracellular region (P=3.43×10-16) in cellular component. The KEGG pathway analysis showed that the DEGs were enriched in the cytokine-cytokine receptor interaction (P=6.86×10-21), chemokine signaling pathway (P=2.03×10-11), systemic lupus erythematosus(P=9.23×10-07), T cell receptor signaling pathway (P=6.59×10-06) and rheumatoid arthritis (P=3.24×10-05). We confirmed RA over-expressed PPI network hub genes included CXCL13, CXCL6, CCR5, CXCR5, CCR2, CXCL3, CXCL10 and RA down-regulated hub genes included SSTR1. Conclusions: The study identified and verified the DEGs between RA and OA synovial tissue which highlighted the activity of a subset of chemokine genes, thereby providing novel insights into the molecular mechanisms of RA pathogenesis and identified potential diagnostic and therapeutic targets for RA.